Human
lung adenocarcinoma A549 cells stably transfected with TPalpha (A549-TPalpha) were used to study agonist
I-BOP-induced expression of
cyclooxygenase-2 (COX-2) and the related mechanisms of induced expression.
I-BOP, a TP agonist, induced a time- and dose-dependent expression of COX-2 in A549-TPalpha cells. The signaling pathways of
I-BOP-induced COX-2 expression were elucidated by using various inhibitors of the signaling molecules. The effects of these inhibitors were assessed at
protein level,
enzyme activity and promoter activity of COX-2. Within MAPK family, both ERK and
p38 MAPK but not JNK/SAPK pathways were involved in the induction. Other pathways such as JAK/Stat3 pathway and
beta-catenin/TCF/LEF pathway also participated in the induction. The activation of key signaling molecules, ERK,
p38 MAPK, CREB and
NF-kappaB, involved in the COX-2 transcription was further studied at the phosphorylation step. Activation of ERK and
p38 MAPK appeared to be mediated primarily by transactivation of EGFR, whereas activation of CREB and
NF-kappaB was mediated by PKA, PKC and ERK. The role of CREB and
NF-kappaB in
I-BOP-induced COX-2 expression was further explored at the promoter level. Studies on promoter fragments and mutation of responsive motifs indicated that CRE and
NF-kappaB sites are critical for the COX-2 induction. Distal
NF-kappaB site is essential for the basal induction of the COX-2 transcription, whereas CRE and proximal
NF-kappaB sites are important for the induced transcription. These results indicate that
I-BOP-induced COX-2 expression through multiple signaling pathways.